References
- Bai Y, Luo Y, Liu S, et al (2011). PRL-1 protein promotes ERK1/2 and RhoA protein activation through a noncanonical interaction with the Src homology 3 domain of p115 Rho GTPase-activating protein. J Biol Chem, 286, 42316-24. https://doi.org/10.1074/jbc.M111.286302
- Bian S, Sun X, Bai A, et al (2013). P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death. PLoS One, 8, 60184. https://doi.org/10.1371/journal.pone.0060184
- Burak K, Angulo P, Pasha TM, et al (2004). Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol, 99, 523-6. https://doi.org/10.1111/j.1572-0241.2004.04067.x
- Deng BG, Yao JH, Liu QY, et al (2013). Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and Maldi-tof mass spectrometry. Asian Pac J Cancer Prev, 14, 6069-75. https://doi.org/10.7314/APJCP.2013.14.10.6069
- Eaton JE, Talwalkar JA, Lazaridis KN, et al (2013). Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology, 145, 521-36. https://doi.org/10.1053/j.gastro.2013.06.052
- Eichhorn PJ, Creyghton MP, Bernards R (2009). Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta, 1795, 1-15.
- Ge F, Xiao CL, Yin XF, et al (2010). Phosphoproteomic analysis of primary human multiple myeloma cells. J Proteomics, 73, 1381-90. https://doi.org/10.1016/j.jprot.2010.03.004
- Goni BW, Yusuph H, Mustapha SK, et al (2013). Hepatic transaminase and alkaline phosphatase enzyme levels in HIV/HBV co-infected and HIV mono-infected patients in Maiduguri, Nigeria. Niger J Clin Pract, 16, 530-4. https://doi.org/10.4103/1119-3077.116908
- Guha U, Chaerkady R, Marimuthu A, et al (2008). Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS. Proc Natl Acad Sci USA, 105, 14112-7. https://doi.org/10.1073/pnas.0806158105
- Kang YK, Kim WH, Jang JJ (2002). Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. Hum Pathol, 33, 877-83. https://doi.org/10.1053/hupa.2002.127444
- Khoontawad J, Hongsrichan N, Chamgramol Y, et al (2014). Increase of exostosin 1 in plasma as a potential biomarker for opisthorchiasis-associated cholangiocarcinoma. Tumour Biol, 35, 1029-39. https://doi.org/10.1007/s13277-013-1137-9
- Kunutsor SK, Apekey TA, Walley J (2013). Liver aminotransferases and risk of incident type 2 diabetes: a systematic review and meta-analysis. Am J Epidemiol, 178, 159-71. https://doi.org/10.1093/aje/kws469
- Lee D, Do IG, Choi K, et al (2012). The expression of phospho- AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas. Mod Pathol, 25, 131-9. https://doi.org/10.1038/modpathol.2011.133
- Letourneux C, Rocher G, Porteu F (2006). B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J, 25, 727-38. https://doi.org/10.1038/sj.emboj.7600980
- Li P, Yang J, Ma QY, et al (2013). Biomarkers screening between preoperative and postoperative patients in pancreatic cancer. Asian Pac J Cancer Prev, 14, 4161-5. https://doi.org/10.7314/APJCP.2013.14.7.4161
- Liang D, Zeng Q, Xu Z, et al (2014). BAFF activates Erk1/2 promoting cell proliferation and survival by Ca2+-CaMKII dependent inhibition of PP2A in normal and neoplastic B-lymphoid cells. Biochem Pharmacol, 87, 332-43. https://doi.org/10.1016/j.bcp.2013.11.006
- Liao MH, Xiang YC, Huang JY, et al (2013). The disturbance of hippocampal CaMKII/PKA/PKC phosphorylation in early experimental diabetes mellitus. CNS Neurosci Ther, 19, 329-36. https://doi.org/10.1111/cns.12084
- Lien SC, Chang SF, Lee PL, et al (2013). Mechanical regulation of cancer cell apoptosis and autophagy: roles of bone morphogenetic protein receptor, Smad1/5, and p38 MAPK. Biochim Biophys Acta, 1833, 3124-33. https://doi.org/10.1016/j.bbamcr.2013.08.023
- Lin J, Adam RM, Santiestevan E, et al (1999). The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. Cancer Res, 59, 2891-7.
- Lowry OH, Rosebrough NJ, Farr AL, et al (1951). Protein measurement with the Folin phenol reagent. J Biol Chem, 193, 265-75.
- Ma L, Chen Z, Erdjument-Bromage H, et al (2005). Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell, 121, 179-93. https://doi.org/10.1016/j.cell.2005.02.031
- Mackinnon A (2000). A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement. Comput Biol Med, 30, 127-34. https://doi.org/10.1016/S0010-4825(00)00006-8
- Malaguarnera G, Paladina I, Giordano M, et al (2013). Serum markers of intrahepatic cholangiocarcinoma. Dis Markers, 34, 219-28. https://doi.org/10.1155/2013/196412
- Martins-de-Souza D, Guest PC, Vanattou-Saifoudine N, et al (2012). Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function. Eur Arch Psychiatry Clin Neurosci, 262, 657-66. https://doi.org/10.1007/s00406-012-0301-3
- Mi H, Muruganujan A, Casagrande JT, et al (2013). Large-scale gene function analysis with the PANTHER classification system. Nat Protoc, 8, 1551-66. https://doi.org/10.1038/nprot.2013.092
- Mitacek EJ, Brunnemann KD, Suttajit M, et al (1999). Exposure to N-nitroso compounds in a population of high liver cancer regions in Thailand: volatile nitrosamine (VNA) levels in Thai food. Food Chem Toxicol, 37, 297-305. https://doi.org/10.1016/S0278-6915(99)00017-4
- Moolthiya P, Tohtong R, Keeratichamroen S, et al (2014). Role of mTOR inhibitor in cholangiocarcinoma cell progression. Oncol Lett, 7, 854-60.
- Rodgers JT, Vogel RO, Puigserver P (2011). Clk2 and B56beta mediate insulin-regulated assembly of the PP2A phosphatase holoenzyme complex on Akt. Mol Cell, 41, 471-9. https://doi.org/10.1016/j.molcel.2011.02.007
- Sacher M, Jiang Y, Barrowman J, et al (1998). TRAPP, a highly conserved novel complex on the cis-Golgi that mediates vesicle docking and fusion. EMBO J, 17, 2494-503. https://doi.org/10.1093/emboj/17.9.2494
- Sahani D, Prasad SR, Tannabe KK, et al (2003). Thorotrastinduced cholangiocarcinoma: case report. Abdom Imaging, 28, 72-4. https://doi.org/10.1007/s00261-001-0148-y
- Skeen JE, Bhaskar PT, Chen CC, et al (2006). Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell, 10, 269-80. https://doi.org/10.1016/j.ccr.2006.08.022
- Sripa B, Kaewkes S, Sithithaworn P, et al (2007). Liver fluke induces cholangiocarcinoma. PLoS Med, 4, 201. https://doi.org/10.1371/journal.pmed.0040201
- Srisomsap C, Sawangareetrakul P, Subhasitanont P, et al (2010). Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes. J Biomed Biotechnol, 2010, 437143.
- Sriwanitchrak P, Viyanant V, Chaijaroenkul W, et al (2011). Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma. Asian Pac J Cancer Prev, 12, 1503-10.
- Thamavit W, Bhamarapravati N, Sahaphong S, et al (1978). Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res, 38, 4634-9.
- Tyson GL, El-Serag HB (2011). Risk factors for cholangiocarcinoma. Hepatology, 54, 173-84.
- van Abel D, Abdulhamid O, Scheper W, et al (2012). STOX1A induces phosphorylation of tau proteins at epitopes hyperphosphorylated in Alzheimer's disease. Neurosci Lett, 528, 104-9. https://doi.org/10.1016/j.neulet.2012.09.017
- van Abel D, Abdulhamid O, Scheper W, et al (2012). STOX1A induces phosphorylation of tau proteins at epitopes hyperphosphorylated in Alzheimer's disease. Neurosci Lett, 528, 104-9. https://doi.org/10.1016/j.neulet.2012.09.017
- Wang X, Stewart PA, Cao Q, et al (2011). Characterization of the phosphoproteome in androgen-repressed human prostate cancer cells by Fourier transform ion cyclotron resonance mass spectrometry. J Proteome Res, 10, 3920-8. https://doi.org/10.1021/pr2000144
- White NM, Masui O, Desouza LV, et al (2014). Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma. Oncotarget.
- Yamada T, Letunic I, Okuda S, et al (2011). iPath2.0: interactive pathway explorer. Nucleic Acids Res, 39, 412-5. https://doi.org/10.1093/nar/gkr313
- Yang CY, Chang CH, Yu YL, et al (2008). PhosphoPOINT: a comprehensive human kinase interactome and phosphoprotein database. Bioinformatics, 24, 14-20. https://doi.org/10.1093/bioinformatics/btn297
- Yonglitthipagon P, Pairojkul C, Chamgramol Y, et al (2012). Prognostic significance of peroxiredoxin 1 and ezrin-radixinmoesin- binding phosphoprotein 50 in cholangiocarcinoma. Hum Pathol, 43, 1719-30. https://doi.org/10.1016/j.humpath.2011.11.021
- Zhang S, Chen Y, Zhu Z, et al (2013). Differential expression of carbohydrate antigen 19-9 in human colorectal cancer: A comparison with colon and rectal cancers. Mol Clin Oncol, 1, 1072-8.